EVICEL Approved for Hemostasis in Surgery


February 21, 2008

In January the FDA granted Ethicon Inc. an expanded indication for EVICEL Fibrin Sealant (Human), which is one of the first fibrin sealants available as an adjunct to hemostasis for use in surgery, when control of bleeding by standard surgical techniques is ineffective or impractical.

EVICEL is an all-human, plasma-derived fibrin. It does not contain aprotinin, which has been associated with adverse health effects. The product is sold as a frozen liquid and requires less than one-minute preparation time after thawing.

February 2008

The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.